1. Covid-19: pharmacotherapeutic insights on various curative approaches in terms of vulnerability, comorbidities, and vaccination

   • Rupinder Kaur
   • Shareen Singh
   • Jiki Robert

   Review 03 January 2022 Pages: 1 - 21

   

2. Pharmaco-immunomodulatory interventions for averting cytokine storm-linked disease severity in SARS-CoV-2 infection

   • Arbind Kumar
   • Aashish Sharma
   • Sanjay Kumar

   Review 20 January 2022 Pages: 23 - 49

   

3. The crosstalk among TLR2, TLR4 and pathogenic pathways; a treasure trove for treatment of diabetic neuropathy

   • Seyed Hossein Aghamiri
   • Khalil Komlakh
   • Mehran Ghaffari

   Review 12 January 2022 Pages: 51 - 60

   

4. Pathophysiological basis in the management of myasthenia gravis: a mini review

   • Aiswarya Binu
   • Sarath S. Kumar
   • Krishnadas Madhu

   Review 21 January 2022 Pages: 61 - 71

5. Cardiac inflammation and fibrosis following chemo/radiation therapy: mechanisms and therapeutic agents

   • Run Yang
   • Changming Tan
   • Masoud Najafi

   Review 23 November 2021 Pages: 73 - 89

   

6. The effects of phytochemicals and herbal bio-active compounds on tumour necrosis factor-α in overweight and obese individuals: a clinical review

   • Mohammad Bagherniya
   • Atena Mahdavi
   • Amirhossein Sahebkar

   Review 08 January 2022 Pages: 91 - 110

   

7. Therapeutic benefits of flavonoids against neuroinflammation: a systematic review

   • Hamsalakshmi
   • Ann Maria Alex
   • Saravana Babu Chidambaram

   Review 15 January 2022 Pages: 111 - 136

   

8. Phenols and terpenoids: natural products as inhibitors of NLRP3 inflammasome in cardiovascular diseases

   • Fang Hua
   • Lingli Shi
   • Peng Zhou

   Review 17 January 2022 Pages: 137 - 147

   

9. The effectiveness of BNT162b2 mRNA vaccine against COVID-19 caused by Delta variant of SARS-CoV-2: a systematic review and meta-analysis

   • Chia Siang Chia Kow
   • Dinesh Sangarran Ramachandram
   • Syed Shahzad Hasan

   Short Communication 31 January 2022 Pages: 149 - 157

   

10. Rutin ameliorates malaria pathogenesis by modulating inflammatory mechanism: an in vitro and in vivo study

    • Divya Bhatt
    • Saurabh Kumar
    • Dnyaneshwar Umrao Bawankule

    Original Article 21 January 2022 Pages: 159 - 171

    

11. Anti-inflammatory and anti-COVID-19 effect of a novel polyherbal formulation (Imusil) via modulating oxidative stress, inflammatory mediators and cytokine storm

    • M. Ratheesh
    • Sujatha Sunil
    • Jayesh Tilwani

    Original Article 25 January 2022 Pages: 173 - 184

    

12. The analgesic effect and safety of preoperative versus postoperative administration of celecoxib in patients who underwent arthroscopic rotator cuff repair: a randomized, controlled study

    • Junfeng Yang
    • Shanfu Wang
    • Jianwei Wang

    Original Article 30 January 2022 Pages: 185 - 191

    

13. Can we predict unresponsiveness to methotrexate in rheumatoid arthritis? A pharmacogenetic study

    • Meltem Alkan Melikoglu
    • Eda Balkan

    Original Article 18 January 2022 Pages: 193 - 197

14. Evaluation serum levels of Insulin Growth Factor-1 (IGF-1) and its association with clinical parameters in severe COVID-19

    • Parisa Feizollahi
    • Somaieh matin
    • Mahdi Taghadosi

    Original Article 31 January 2022 Pages: 199 - 205

    

15. Comparison of the antibacterial activity of Australian Terminalia spp. extracts against Klebsiella pneumoniae: a potential treatment for ankylosing spondylitis

    • Reece Courtney
    • Ian Edwin Cock

    Original Article 06 January 2022 Pages: 207 - 223

    

16. Anti-inflammatory potential of cannabidiol (CBD) on combination of caecal slurry, LPS, and E. coli-induced systemic inflammatory response syndrome (SIRS) in Sprague Dawley Rats

    • Mahendra Kumar Trivedi
    • Sambhu Mondal
    • Snehasis Jana

    Original Article 08 January 2022 Pages: 225 - 232

    

17. Metformin effect in models of inflammation is associated with activation of ATP-dependent potassium channels and inhibition of tumor necrosis factor-α production

    • Paulo S. A. Augusto
    • Tamires C. Matsui
    • Renes R. Machado

    Original Article 30 November 2021 Pages: 233 - 241

    

18. The effects of metformin, pioglitazone, exenatide and exercise on fatty liver in obese diabetic rats: the role of IRS-1 and SOCS-3 molecules

    • Kemal Ozan Lule
    • Ersin Akarsu
    • Ibrahim Yilmaz

    Original Article 24 January 2022 Pages: 243 - 250

    

19. Protective effect of methyl gallate on murine antigen-induced arthritis by inhibiting inflammatory process and bone erosion

    • Luana Barbosa Correa
    • Tatiana Almeida Pádua
    • Maria G. Henriques

    Original Article 02 February 2022 Pages: 251 - 266

    

20. Alterations to microbial secretome by estrogen may contribute to sex bias in irritable bowel syndrome

    • Lesha Pretorius
    • Anton du Preez Van Staden
    • Carine Smith

    Original Article 13 January 2022 Pages: 267 - 281

    

21. Topical phenytoin administration accelerates the healing of acetic acid-induced colitis in rats: evaluation of transforming growth factor-beta, platelet-derived growth factor, and vascular endothelial growth factor

    • Nima Fattahi
    • Alina Abdolahi
    • Mohammad Raman Moloudi

    Original Article 13 January 2022 Pages: 283 - 290

    

22. In vitro and in vivo anti-inflammatory activity of Tetrastigma sulcatum leaf extract, pure compound and its derivatives

    • Ravindra Jagannath Waghole
    • Ashwini Vivek Misar
    • Sachin Hanmant Jadhav

    Original Article 22 January 2022 Pages: 291 - 311

    

23. Montelukast suppresses the development of irritable bowel syndrome phenotype possibly through modulating NF-κB signaling in an experimental model

    • Pariya Khodabakhsh
    • Nilgoon Khoie
    • Hamed Shafaroodi

    Original Article 10 January 2022 Pages: 313 - 325

    

24. Curcumin and n-acetylcysteine cocrystal produced with supercritical solvent: characterization, solubility, and preclinical evaluation of antinociceptive and anti-inflammatory activities

    • Alessandro R. Paulazzi
    • Bianca O. Alves
    • Liz Girardi Müller

    Original Article 10 January 2022 Pages: 327 - 341

    

25. NSAIDs and Kelleni’s protocol as potential early COVID-19 treatment game changer: could it be the final countdown?

    • Mina T. Kelleni

    Commentary 25 November 2021 Pages: 343 - 348

26. Mechanism by which immune complexes are deposited in hosts tissue

    • Isaac Ginsburg
    • Mark Feldman

    Commentary 18 January 2022 Pages: 349 - 351

27. Correction to: The effect of glutamine supplementation on serum levels of some inflammatory factors, oxidative stress, and appetite in COVID-19 patients: a case–control study

    • Mahsa Mohajeri
    • Ehsan Horriatkhah
    • Reza Mohajery

    Correction 20 December 2021 Pages: 353 - 353